Cancer incidence in immunocompromised patients: a single-center cohort study.

Saved in:
Bibliographic Details
Title: Cancer incidence in immunocompromised patients: a single-center cohort study.
Authors: Ilham S; Department of Pharmacotherapy, College of Pharmacy, L. S. Skaggs Pharmacy Institute, University of Utah, 30 2000 E, Salt Lake City, UT, 84112, USA., Willis C; Department of Pharmacotherapy, College of Pharmacy, L. S. Skaggs Pharmacy Institute, University of Utah, 30 2000 E, Salt Lake City, UT, 84112, USA., Kim K; Department of Pharmacotherapy, College of Pharmacy, L. S. Skaggs Pharmacy Institute, University of Utah, 30 2000 E, Salt Lake City, UT, 84112, USA.; Department of Pharmacy Systems, Outcomes and Policy, University of Illinois, Chicago, IL, USA., Chung KC; GRAIL, LLC, a subsidiary of Illumina, Inc., currently held separate from Illumina Inc, Menlo Park, CA, USA., Wood BM; GRAIL, LLC, a subsidiary of Illumina, Inc., currently held separate from Illumina Inc, Menlo Park, CA, USA., Tan MS; Department of Pharmacotherapy, College of Pharmacy, L. S. Skaggs Pharmacy Institute, University of Utah, 30 2000 E, Salt Lake City, UT, 84112, USA., Tan CJ; Department of Pharmacotherapy, College of Pharmacy, L. S. Skaggs Pharmacy Institute, University of Utah, 30 2000 E, Salt Lake City, UT, 84112, USA., Nguyen DT; Department of Pharmacotherapy, College of Pharmacy, L. S. Skaggs Pharmacy Institute, University of Utah, 30 2000 E, Salt Lake City, UT, 84112, USA., Brixner DI; Department of Pharmacotherapy, College of Pharmacy, L. S. Skaggs Pharmacy Institute, University of Utah, 30 2000 E, Salt Lake City, UT, 84112, USA. diana.brixner@utah.edu., Stenehjem DD; Department of Pharmacotherapy, College of Pharmacy, L. S. Skaggs Pharmacy Institute, University of Utah, 30 2000 E, Salt Lake City, UT, 84112, USA.; Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Duluth, MN, USA.
Source: BMC cancer [BMC Cancer] 2023 Jan 09; Vol. 23 (1), pp. 33. Date of Electronic Publication: 2023 Jan 09.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1471-2407
DOI:10.1186/s12885-022-10497-4